Download PDF
Drug Res (Stuttg) 2015; 65(12): 645-649
DOI: 10.1055/s-0034-1398550
Original Article
© Georg Thieme Verlag KG Stuttgart · New York

Involvement of Descending Serotonergic and Noradrenergic Systems and their Spinal Receptor Subtypes in the Antinociceptive Effect of Dipyrone

A. Gencer
1   Department of Medical Pharmacology, Faculty of Medicine, Trakya University, Edirne, Turkey
,
O. Gunduz
1   Department of Medical Pharmacology, Faculty of Medicine, Trakya University, Edirne, Turkey
,
A. Ulugol
1   Department of Medical Pharmacology, Faculty of Medicine, Trakya University, Edirne, Turkey
› Author Affiliations
Further Information

Publication History

received 30 October 2014

accepted 02 January 2015

Publication Date:
03 February 2015 (online)

Also available at
    Permissions and Reprints

Abstract

The antinociceptive effect of dipyrone is partly due to its action upon pain-related central nervous system structures. Despite intensive research, the precise mechanisms mediating its analgesic effects remain unclear. Here, we aimed to determine whether neurotoxic destruction of descending inhibitory pathways affect dipyrone-induced antinociception and whether various spinal serotonergic and adrenergic receptors are involved in this antinociception. The nociceptive response was assessed by the tail-flick test. Mice injected with dipyrone (150, 300, 600 mg/kg, i.p.) elicited dose-related antinociception. The neurotoxins 5,7-dihydroxytryptamine (50 μg/mouse) and 6-hydroxydopamine (20 μg/mouse) are applied intrathecally to deplete serotonin and noradrenaline in the spinal cord. 3 days after neurotoxin injections, a significant reduction in the antinociceptive effect of dipyrone was observed. Intrathecal administration of monoaminergic antagonists (10 μg/mouse), the 5-HT2a antagonist ketanserin, the 5-HT3 antagonist ondansetron, the 5-HT7 antagonist SB-258719, α1-adrenoceptor antagonist prazosin, α2-adrenoceptor antagonist yohimbine, and the β-adrenoceptor antagonist propranolol also attenuated dipyrone antinociception. We propose that descending serotonergic and noradrenergic pathways play pivotal role in dipyrone-induced antinociception and spinal 5-HT2a, 5-HT3, and 5-HT7-serotonergic and α1, α2, and β-adrenergic receptors mediate this effect.

Key words

antinociception - descending inhibition - dipyrone - noradrenergic system - serotonergic system
 

  • References

  • 1 Lorenzetti BB, Ferreira SH. Activation of the arginine-nitric oxide pathway in primary sensory neurons contributes to dipyrone-induced spinal and peripheral analgesia. Inflamm Res 1996; 45: 308-311
    CrossrefPubMedGoogle Scholar
  • 2 Alves DP, Duarte IDG. Involvement of ATP-sensitive K+ channels in the peripheral antinociceptive effect induced by dipyrone. Eur J Pharmacol 2002; 444: 47-52
    CrossrefPubMedGoogle Scholar
  • 3 Dos Santos GG, Dias EV, Teixeira JM et al. The analgesic effect of dipyrone in peripheral tissue involves two different mechanisms: Neuronal K channel opening and CB receptor activation. Eur J Pharmacol 2014; 741C: 124-131
    PubMedGoogle Scholar
  • 4 Hernandez-Delgadillo GP, Cruz SL. Endogenous opioids are involved in morphine and dipyrone analgesic potentiation in the tail flick test in rats. Eur J Pharmacol 2006; 546: 54-59
    CrossrefPubMedGoogle Scholar
  • 5 Vanegas H, Tortorici V. Opioidergic effects of nonopioid analgesics on the central nervous system. Cell Mol Neurobiol 2002; 22: 655-661
    CrossrefPubMedGoogle Scholar
  • 6 Vazquez E, Hernandez N, Escobar W et al. Antinociception induced by intravenous dipyrone (metamizol) upon dorsal horn neurons: involvement of endogenous opioids at the periaqueductal gray matter, the nucleus raphe magnus, and the spinal cord in rats. Brain Res 2005; 1048: 211-217
    CrossrefPubMedGoogle Scholar
  • 7 Akman H, Aksu F, Gultekin I et al. A possible central antinociceptive effect of dipyrone in mice. Pharmacology 1996; 53: 71-78
    CrossrefPubMedGoogle Scholar
  • 8 Carlsson KH, Jurna I. The Role of Descending Inhibition in the Antinociceptive Effects of the Pyrazolone Derivatives, Metamizol (Dipyrone) and Aminophenazone (Pyramidon). N-S Arch Pharmacol 1987; 335: 154-159
    PubMedGoogle Scholar
  • 9 Rogosch T, Sinning C, Podlewski A et al. Novel bioactive metabolites of dipyrone (metamizol). Bioorgan Med Chem 2012; 20: 101-107
    CrossrefPubMedGoogle Scholar
  • 10 Escobar W, Ramirez K, Avila C et al. Metamizol, a non-opioid analgesic, acts via endocannabinoids in the PAG-RVM axis during inflammation in rats. Eur J Pain 2012; 16: 676-689
    CrossrefPubMedGoogle Scholar
  • 11 Campos C, de Gregorio R, Garcia-Nieto R et al. Regulation of cyclooxygenase activity by metamizol. Eur J pharmacol 1999; 378: 339-347
    CrossrefPubMedGoogle Scholar
  • 12 Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals [editorial]. Pain 1983; 16: 109-110
    CrossrefPubMedGoogle Scholar
  • 13 Hung KC, Wu HE, Mizoguchi H et al. Intrathecal treatment with 6-hydroxydopamine or 5,7-dihydroxytryptamine blocks the antinociception induced by endomorphin-1 and endomorphin-2 given intracerebroventricularly in the mouse. J Pharmacol Sci 2003; 93: 299-306
    CrossrefPubMedGoogle Scholar
  • 14 Bjorklund A, Baumgarten HG, Rensch A. 5,7-Dihydroxytryptamine – Improvement of Its Selectivity for Serotonin Neurons in Cns by Pretreatment with Desipramine. J Neurochem 1975; 24: 833-835
    CrossrefPubMedGoogle Scholar
  • 15 Dogrul A, Seyrek M, Akgul EO et al. Systemic paracetamol-induced analgesic and antihyperalgesic effects through activation of descending serotonergic pathways involving spinal 5-HT7 receptors. Eur J Pharmacol 2012; 677: 93-101
    CrossrefPubMedGoogle Scholar
  • 16 Seyrek M, Kahraman S, Deveci MS et al. Systemic cannabinoids produce CB1-mediated antinociception by activation of descending serotonergic pathways that act upon spinal 5-HT7 and 5-HT2A receptors. Eur J Pharmacol 2010; 649: 183-194
    CrossrefPubMedGoogle Scholar
  • 17 Hylden JL, Wilcox GL. Intrathecal morphine in mice: a new technique. Eur J Pharmacol 1980; 67: 313-316
    CrossrefPubMedGoogle Scholar
  • 18 Yilmaz I, Ulugol A. The Effect of Nitric Oxide Synthase Inhibitors on the Development of Analgesic Tolerance to Dipyrone in Mice. Int J Neurosci 2009; 119: 755-764
    CrossrefPubMedGoogle Scholar
  • 19 Elmas P, Ulugol A. Involvement of cannabinoid CB1 receptors in the antinociceptive effect of dipyrone. J Neural Transm 2013; 120: 1533-1538
    CrossrefPubMedGoogle Scholar
  • 20 Ochi T, Goto T. The antinociceptive effect induced by FR140423 is mediated through spinal 5-HT2A and 5-HT3 receptors. Eur J Pharmacol 2000; 409: 167-172
    CrossrefPubMedGoogle Scholar
  • 21 Ochi T, Goto T. The antinociceptive effect of FR140423 in mice: involvement of spinal alpha(2)-adrenoceptors. Eur J Pharmacol 2000; 400: 199-203
    CrossrefPubMedGoogle Scholar
  • 22 Millan MJ. Descending control of pain. Prog Neurobiol 2002; 66: 355-474
    CrossrefPubMedGoogle Scholar
  • 23 Tjolsen A, Berge OG, Hole K. Lesions of Bulbo-Spinal Serotonergic or Noradrenergic Pathways Reduce Nociception as Measured by the Formalin Test. Acta Physiol Scand 1991; 142: 229-236
    CrossrefPubMedGoogle Scholar
  • 24 Mallet C, Daulhac L, Bonnefont J et al. Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia. Pain 2008; 139: 190-200
    CrossrefPubMedGoogle Scholar
  • 25 Godoy MCM, Fighera MR, Souza FR et al. alpha(2)-adrenoceptors and 5-HT receptors mediate the antinociceptive effect of new pyrazolines, but not of dipyrone. Eur J Pharmacol 2004; 496: 93-97
    CrossrefPubMedGoogle Scholar
  • 26 Beirith A, Santos ARS, Rodrigues ALS et al. Spinal and supraspinal antinociceptive action of dipyrone in formalin, capsaicin and glutamate tests. Study of the mechanism of action. Eur J Pharmacol 1998; 345: 233-245
    CrossrefPubMedGoogle Scholar
  • 27 Courade JP, Chassaing C, Bardin L et al. 5-HT receptor subtypes involved in the spinal antinociceptive effect of acetaminophen in rats. Eur J Pharmacol 2001; 432: 1-7
    CrossrefPubMedGoogle Scholar
  • 28 Rahman W, Bannister K, Bee LA et al. A pronociceptive role for the 5-HT2 receptor on spinal nociceptive transmission: An in vivo electrophysiological study in the rat. Brain Res 2011; 1382: 29-36
    CrossrefPubMedGoogle Scholar
  • 29 Mattia C, Coluzzi F. What anesthesiologists should know about paracetamol (acetaminophen). Minerva Anestesiol 2009; 75: 644-653
    PubMedGoogle Scholar
  • 30 Smith HS. Potential Analgesic Mechanisms of Acetaminophen. Pain Physician 2009; 12: 269-280
    PubMedGoogle Scholar
  • 31 Yaksh TL, Pogrel JW, Lee YW et al. Reversal of Nerve Ligation-Induced Allodynia by Spinal Alpha-2-Adrenoceptor Agonists. J Pharmacol Exp Ther 1995; 272: 207-214
    PubMedGoogle Scholar
  • 32 Takano Y, Yaksh TL. Characterization of the Pharmacology of Intrathecally Administered Alpha-2 Agonists and Antagonists in Rats. J Pharmacol Exp Ther 1992; 261: 764-772
    PubMedGoogle Scholar
  • 33 Howe JR, Wang JY, Yaksh TL. Selective Antagonism of the Anti-Nociceptive Effect of Intrathecally Applied Alpha-Adrenergic Agonists by Intrathecal Prazosin and Intrathecal Yohimbine. J Pharmacol Exp Ther 1983; 224: 552-558
    PubMedGoogle Scholar
  • 34 Bylund DB, Rayprenger C, Murphy TJ. Alpha-2a and Alpha-2b Adrenergic-Receptor Subtypes – Antagonist Binding in Tissues and Cell-Lines Containing Only One Subtype. J Pharmacol Exp Ther 1988; 245: 600-607
    PubMedGoogle Scholar
  • 35 Uchihashi Y, Kamei M, Fukuda I et al. Effects of alpha adrenoreceptor antagonists, prazosin and yohimbine, on intrathecal lidoeaine-induced antinociception in mice. Acta Anaesth Scand 2000; 44: 1083-1086
    CrossrefPubMedGoogle Scholar
  • 36 Peng YI, Liu HJ, Fu TC. Involvement of alpha- and beta-adrenoceptors in antinociception at the lumber spinal level in mice. The Chinese journal of physiology 1993; 36: 177-180
    PubMedGoogle Scholar
  • 37 Engel G, Gothert M, Hoyer D et al. Identity of Inhibitory Presynaptic 5-Hydroxytryptamine (5-Ht) Autoreceptors in the Rat-Brain Cortex with 5-Ht1b Binding-Sites. N-S Arch Pharmacol 1986; 332: 1-7
    PubMedGoogle Scholar
  • 38 Hamon M, Lanfumey L, Elmestikawy S et al. The Main Features of Central 5-Ht1 Receptors. Neuropsychopharmacology 1990; 3: 349-360
    PubMedGoogle Scholar
  • 39 Chen YW, Chu CC, Chen YC et al. Intrathecal propranolol displays long-acting spinal anesthesia with a more sensory-selective action over motor blockade in rats. Eur J Pharmacol 2011; 667: 208-214
    CrossrefPubMedGoogle Scholar